US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.06

-0.5499-0.89%

Volume:34.77K

Turnover:2.11M

Market Cap:285.15M

PE:19.97

High:61.59

Open:61.59

Low:60.44

Close:61.61

52wk High:64.10

52wk Low:39.36

Shares:4.67M

Float Shares:4.67M

Volume Ratio:2.04

T/O Rate:0.74%

Dividend:1.53

Dividend Rate:2.50%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Revolution Medicines, Inc. : Morgan Stanley Initiates Coverage with Overweight Rating; Price Target $255

THOMSON REUTERS

BeOne Medicines FY26 H1 Net Income Climbs to Us$464.36 Million; Revenue Rises 32.3% to Us$3.22 Billion

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live

Roivant Sciences Price Target Raised to $46.00/Share from $42.00 by Guggenheim

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Top Midday Gainers

MT Newswires Live

Roivant Sciences price target raised to $47 from $41 at H.C. Wainwright

Roivant Sciences rises 17.6%

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co

Top Premarket Gainers

MT Newswires Live

Roivant Sciences Shares Rise on Positive Mid-Stage Trial Results

Roivant Sciences Jumps After Lung Disease Drug Meets Main Goal in Mid-Stage Study

Shares of Roivant Sciences up 21.1% Premarket After Experimental Lung Disease Drug Meets Main Goal in Mid-Stage Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.061,"timestamp":1789494152446,"preClose":61.6109,"halted":0,"volume":34771,"delay":0,"changeRate":-0.0089253687253392,"floatShares":4670000,"shares":4670000,"eps":3.057033,"marketStatus":"Trading","change":-0.5499,"latestTime":"09-15 13:43:02 EDT","open":61.585,"high":61.585,"low":60.44,"amount":2110839.96761,"amplitude":0.018584,"askPrice":60.76,"askSize":300,"bidPrice":60.67,"bidSize":100,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.6109,"sharesOutstanding":2480000,"nav":60.75567,"aum":283728978.9,"dividendRate":0.025024,"bidAskSpread":0.001903,"postHourTrading":{"tag":"盘后","latestPrice":61.66,"preClose":61.6109,"latestTime":"19:30 EDT","volume":13,"amount":800.5754,"timestamp":1789428602402,"change":0.0491,"changeRate":0.000797,"amplitude":0},"volumeRatio":2.04069,"impliedVol":0.1251,"impliedVolPercentile":0.5458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.04069,"shares":4670000,"dividePrice":1.528,"high":61.585,"amplitude":0.018584,"preClose":61.6109,"low":60.44,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.061,"committee":-0.5,"eps":3.057033,"divideRate":0.025024,"volume":34771,"delay":0,"ttmEps":3.057033,"open":61.585,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.7173,"twentyDayClose":60.8616,"sixtyDayClose":52.9818},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666640045","title":"Revolution Medicines, Inc. : Morgan Stanley Initiates Coverage with Overweight Rating; Price Target $255","url":"https://stock-news.laohu8.com/highlight/detail?id=2666640045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666640045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:09","pubTimestamp":1789034986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVMD","CANC","IE0009355771.USD","IE00B2B36J28.USD","IDNA","BBH","IE0009354923.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","PTH","IE00BFTCPJ56.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566940","title":"BeOne Medicines FY26 H1 Net Income Climbs to Us$464.36 Million; Revenue Rises 32.3% to Us$3.22 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566940","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666566940?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:32","pubTimestamp":1789029138,"startTime":"0","endTime":"0","summary":"BeOne Medicines FY26 H1 net income climbs to US$464.36 million; revenue rises 32.3% to US$3.22 billionBeOne Medicines posted GAAP net income of US$464.36 million, swinging from profit of US$95.59 mill","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4kr7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","PTH","LU0320765992.SGD","BK4139","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009354923.USD","IE00BJJMRZ35.SGD","BBH","IDNA","RVMD","688235","BK0239","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0889565916.HKD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","09996","BK0042","BK1574","159883","LNGR","PTH","MDEV","300642","GDOC","RSPH","BK1583","IEIH","HART","BK0046","BK0239","BK1100","LGHT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HART","MDEV","LNGR","BK1583","MEDX","01302","BK1100","AGNG","IEIH","BK1574","LGHT","PTH","159883","RSPH","BK1600","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368655","title":"UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368655","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960920,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $198.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EKG","FFOX","GDOC","HELX","BK4196","GNMX","BK4585","LU0320765992.SGD","PTH","BK4535","LU0109394709.USD","GNOM","BK4588","GH","LFSC","BK4551","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666041535","title":"Roivant Sciences Price Target Raised to $46.00/Share from $42.00 by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2666041535","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666041535?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:30","pubTimestamp":1788960600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTH","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666769587","title":"Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666769587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666769587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952232,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Collegium Pharmaceutical (COLL), Revolution Medicine...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4581","BK4588","LABU","XLV","NTLA","IDNA","IE0002141913.USD","LU0889565916.HKD","LU0320765992.SGD","BK4535","BK4139","PTH","BK4585","HCSG","LU0029874061.USD","RVMD","IE00BFTCPJ56.SGD","XBI","LU1861558580.USD","IE0009355771.USD","BK4007","BBH","IE00B2B36J28.USD","BK4137","CANC","LU0128526141.USD","BK4556","LU1861559042.SGD","COLL","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","FHLC","IDNA","GDOC","AZNH","MEDX","SYNB","SURI","MNTL","TBXU","IEIH","BME","WDNA","GNMX","LLYX","PBE","HRTS","SBIO","NVIB","FBT","LFSC","PJP","MEDI","FTXH","MDTX","APXH","GNOM","IBRN","GSKH","BBP","XPH","PTH","RSPH","CURE","FXH","JDOC","JHMH","IBBQ","PINK","PSIL","IBBJ","IBB","MRNY","PBPH","BBH","HYLG","PSCH","BIB","CANC","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666637458","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666637458","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666637458?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:27","pubTimestamp":1788888467,"startTime":"0","endTime":"0","summary":"Roivant Sciences  shares soared 19% after the company said its Pulmovant unit's phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD, met its primary and secondary endpoints.More than 13.5 million shares of the company traded intraday compared with a daily average of about 6.26 million.Intel  is expected to raise personal computer central processing unit prices by another 10% in early October, Digitimes reported, citing supply chain sources.Shares jumped 10%, with intraday trading volume at over 86.0 million, versus the stock's daily average of about 113.4 million.Pharvaris  said that a global phase 3 study of deucrictibant extended-release tablets met the primary endpoint of reducing the mean monthly attack rate by 83%, compared with placebo, in people with hereditary angioedema.Wedbush Securities adjusted Pharvaris' price target to $50 from $42 while maintaining its outperform rating.Shares climbed 10% as int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0859254822.USD","BK4612","LINT","IE000WAW04H5.SGD","LU0187121727.USD","IE000M9KFDE8.USD","LU0251131958.USD","SINTCmain","LU0274383776.USD","LU0097036916.USD","LU0719512351.SGD","DRIV","BK4579","LU2543165471.USD","LU0321505439.SGD","BK4533","PHVS","SOXX","04335","LU0149725797.USD","BK4141","TTEQ","BK4588","IE000MB6IJN5.SGD","BK4585","INTW","INYY","LU2089985449.USD","HK0000304797.USD","BK4575","BK4515","LU2764263203.CNY","ROIV","LU2357627491.SGD","LU2148611432.USD","BK4534","HK0000304805.HKD","XNTK","INTC","LU0081259029.USD","LU0251142724.SGD","BK4602","BK4529","INT","LU0154236417.USD","BK4527","LU2764263039.SGD","LU2764262908.HKD","LU0082616367.USD","FTXL","LU2360106780.USD","AIS","LU0048573561.USD","IE000BZT7R73.USD","QQQA","LU2931357623.SGD","CHPS","LEGR","BK4543","LU2244417387.USD","BK4139","BK4554","LU0742534661.SGD","LU1852331112.SGD","LU2250418816.HKD","IE000F7OJYX1.SGD","IE000SO60NU8.SGD","IE0000B7K699.USD","BK4605","LU0056508442.USD","AIQ","BK4007","BK4535","LU0321505868.SGD","BK4512","PTH","BK4550","LU2720916845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666492371","title":"Roivant Sciences price target raised to $47 from $41 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2666492371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666492371?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:35","pubTimestamp":1788885318,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Roivant Sciences (ROIV) to $47 from $41 and keeps a Buy rating on the shares. The firm believes m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-47-from-41-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-47-from-41-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PTH","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376643","title":"Roivant Sciences rises 17.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376643?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:05","pubTimestamp":1788876358,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) is up 17.6%, or $6.15 to $41.08. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-17-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-17-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665752763","title":"U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665752763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665752763?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:57","pubTimestamp":1788875845,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, NovartisSeptember 8 (Reuters)-Wall Street's main indexes were mixed at open on Tuesday as fresh hostilities in the Middle East pushed oil price","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL6N4500HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","BEC","BK4534","WQTM","SEI","LU0109394709.USD","GNOM","IBAT","IE0009354923.USD","IONS","LU2242649171.HKD","LU2357125470.USD","LU1548497426.USD","LU2543165471.USD","NTLA","LU2265009873.SGD","BK4124","LU0957808578.USD","LU2242652126.USD","UPGR","LU0476273544.USD","SGML","TBXU","BHVN","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4578","IBB","BEX","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1153585028.USD","LU2244417387.USD","VTWG","ABM","PUL","LU1303367103.USD","LU0433182093.SGD","USNG","ILMN","LU2506951875.HKD","LU2098885051.SGD","LU1804176565.USD","QTUP","UNFI","LU1720051017.SGD","IE00B2B36J28.USD","IONQ","PTH","LU1988902786.USD","LU2362540622.SGD","BK4602","DYN","BK4599","BBH","LU0077335932.USD","LU1815336760.USD","LU0444971666.USD","LU0187121727.USD","LU2506952170.USD","RGTI","BK4533","RGTU","BK4504","SRPT","BK4585","PPH","LU0985489474.SGD","XES","LU0154245673.USD","BK4007","EGGY","LU1642822529.SGD","BK4168","LU1057294990.SGD","ICLN","CTEC","RGTC","BK4121","RGTX","LU0267386448.USD","CQTM","LU0211331839.USD","SIMS","IE0034235188.USD","LU0345769631.USD","CHRW","IOYY","LU2294711713.HKD","GNMX","LU1489326972.SGD","LU1983299246.USD","LU0266013472.USD","LU2491050154.USD","LU0029874061.USD","FRNW","LU0058720904.USD","IONC","PJP","BK4170","LU2506951792.HKD","BK4541","LU0432979614.USD","ZAP","LU1861559042.SGD","BIB","LU1291159041.SGD","BK4209","BK4532","LU0320765992.SGD","LU1989772840.SGD","BE","LU0353189763.USD","IBBQ","LU2242646821.SGD","RGTZ","LU2506952097.USD","LU2264538146.SGD","LU0208291251.USD","BEZ","LU0878866978.SGD","LU1718418525.SGD","BK4591","BK4082","PHVS","BK4535","LU1861558580.USD","LU0320765489.SGD","PBE","LU0070302665.USD","LU1989771016.USD","BK4182","SHAK","IE0009355771.USD","LU2491049909.HKD","SMOG","WATS","04332","LU1791710400.SGD","MEDX","LU0225283273.USD","SRPU","CNRG","LU2249611893.SGD","LU2468319806.SGD","LU0823417737.USD","LU0950375773.USD","LU2491050071.SGD","LU0068578508.USD","LU1989772923.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BSX","BK4131","RGYY","LU2357305700.SGD","LU1064131342.USD","LU0823414551.USD","IONZ","LU0823414478.USD","BK4548","LU0444973449.USD","LU1720051108.HKD","IE00B4R5TH58.HKD","BK4505","LU0889565916.HKD","LU2362541273.HKD","IE0031619046.USD","SG9999013999.USD","LU0138981039.USD","AMGN","BK4581","SG9999001440.SGD","BK4102","LU0011850046.USD","BEG","BK4588","LU0114720955.EUR","LU1061106388.HKD","LU1878469433.USD","IE00BFTCPJ56.SGD","BK4566","LU2112291526.USD","OIH","IE00B66KJ199.SGD","LU2506951958.HKD","LU1093756168.USD","IONX","LU0289739699.SGD","LU1093756325.SGD","LU0882574055.USD","LU2089984988.USD","BK4139","LU0823416689.USD","SG9999001176.USD","LU0823417653.USD","LU1571399168.USD","ALV","P","LU0048584097.USD","SGXZ57979304.SGD","BK4556","NVS","LU0251132253.USD","BK4120","LU1366192091.USD","LU2362541513.USD","LU1989764664.SGD","BK4597","LU1791710582.SGD","LU0154245756.USD","VCLN","LU0128526141.USD","LU0238689110.USD","LU2324357040.USD","LU1023059063.AUD","LU2087625088.SGD","LU0528227936.USD","LU0345769128.USD","SG9999001176.SGD","LU0353189680.USD","ROIV","IONL","BK4567","BK4179","HYDR","LU0868494617.USD","LU1989764748.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665891373","title":"Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665891373","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665891373?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:55","pubTimestamp":1788872154,"startTime":"0","endTime":"0","summary":"(Updates with economic data, recent oil price movement, world markets' overview and corporate stock movements.)US equity futures were mostly lower pre-bell Tuesday, coming off a three-day weekend as t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","LU1734074674.USD","LU2247934214.USD","LU2324357040.USD","LU1934455277.USD","BK4543","BK4581","IE00BQXX3F31.USD","LU0109392836.USD","LU2249611893.SGD","DBEU","LU1720051108.HKD","TSM","LU1852331112.SGD","LU1989772923.USD","LU2089283258.USD","LU1974910355.USD","IE0004091025.USD","IE00B3M56506.USD","LU0138981039.USD","SGXZ99366536.SGD","LU0823434583.USD","EFA","BK4527","LU2360106780.USD","LU2471134796.USD","TEK","AVXC","LU2125154935.USD","LU1267930813.SGD","LU0792757196.USD","LU0345769631.USD","TSMX","LU2543165471.USD","LU2063271972.USD","CORO","LU0077335932.USD","LU0572939691.SGD","PQNT","TSMG","LU2089284900.SGD","IE00BKPKM429.USD","BK4604","SGXZ57979304.SGD","BK4588","LU2125154778.USD","CWI","LU0264606111.USD","THNR","SPWO","IE0004086264.USD","BK4526","LU0950375773.USD","LU1803068979.SGD","LU2106854487.HKD","IE00BQXX3D17.EUR","ROIV","IE00BHPRN162.USD","LU0175139822.USD","LU2471134952.CNY","IE00BFXG0V08.USD","LU2298321311.HKD","LU2211814178.USD","LU2357125470.USD","LU2092937221.SGD","LU0122379950.USD","BK4585","LU2244417387.USD","IE00BYQQ9H92.USD","SPTE","PPA","ASMU","LU0345774631.USD","LU0211331839.USD","LU0098860793.USD","LU0348723411.USD","LU0878004406.USD","LU1037948897.HKD","LU1323610961.USD","LU0359201612.USD","SGXZ81514606.USD","CNEQ","IE00BKVL7J92.USD","LU0345769128.USD","NVOH","IE00B2B36J28.USD","LU1934455863.HKD","LU1037948541.HKD","LU2054465674.USD","LU1548497426.USD","LU2663582299.SGD","LU0251132253.USD","LU0289960550.SGD","SMH","ASMZ","LU0267386448.USD","DBEF","LU0158827781.USD","SG9999013999.USD","LU0211328371.USD","LU0878005551.USD","LU0823414478.USD","IE00BZ199S13.USD","ADVE","SG9999000418.SGD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU0823417653.USD","LU2237443382.USD","LU0225283273.USD","LU1244550494.USD","IE00B5TLWC47.USD","TTEQ","LU0359202008.SGD","LU0345774391.USD","LU2211815571.USD","IE00BJJMRZ35.SGD","LU2360032135.SGD","BK4141","LU2023251221.USD","BK4554","LU2360108059.USD","MEDX","LU0124676726.USD","LU1244550577.SGD","TWSC","LU1929549753.HKD","IE0002141913.USD","IE0004445239.USD","LU0094547139.USD","BK4591","LU0541502299.USD","NVS","BSX","LU2750360997.AUD","ESIM","PTH","LU0143863784.USD","LU0154236417.USD","LU0198837287.USD","SG9999001176.SGD","LU0316494557.USD","LU0208291251.USD","TSMU","LU1917777945.USD","03145","BK4605","LU0097036916.USD","LU1868837722.USD","LU1048588211.SGD","ASML","LU1989764748.USD","LU2506951792.HKD","ASMH","CHPX","IFLR","AIQ","LU0187121727.USD","LU2133065610.SGD","LU0965509283.SGD","LU0320765646.SGD","LU1720051017.SGD","LU0965509010.AUD","LMTL","LU0823421333.USD","LU2250418816.HKD","EMC","TINS","NATO","BK4504","LU0238689110.USD","LU0823417737.USD","LU2112291526.USD","LU1057294990.SGD","IEFA","LU2294711713.HKD","LU1211504680.USD","LU0965509101.SGD","IE00BQXX3C00.GBP","LU1868837565.USD","LU0823414551.USD","LU2362540622.SGD","LU0541501648.USD","LU1718418525.SGD","BK4139","BK4534","IE00B4R5TH58.HKD","LU2458330169.SGD","GSID","LU1712237335.SGD","BK4612","LU1983299246.USD","CGGO","LU2237443622.USD","LU2087625088.SGD","LU1282649810.SGD","LU1061106388.HKD","SGXZ51526630.SGD","LU2242649171.HKD","LU0719512351.SGD","LU1804176565.USD","PPH","LU2362541273.HKD","BK4533","SG9999001176.USD","ASMG","LU0642271901.SGD","LU2041044095.USD","BK4147","TSMZ","LU0889566641.SGD","LU2265009873.SGD","ASIA","BK4602","FFGX","LU0143863198.USD","LU2750360641.GBP","LU0056508442.USD","LU0320765489.SGD","LU0353189763.USD","03165","LU2111349929.HKD","LU0689626769.HKD","BK4505","ILOW","LU1244550221.USD","BK4532","LU0823421416.USD","LU0353189680.USD","LU2471134523.USD","EPAI","LU1267930490.SGD","BK4082","LU0572940350.SGD","NVOC","LU0266013472.USD","LU0048584097.USD","LMTS","DIPR","WUGI","LU2506952097.USD","LU1989771016.USD","LU0158827948.USD","LU1153585028.USD","BLOX","IE00BD6J9T35.USD","CGNG","LU1093756168.USD","AVSE","LU2237443549.SGD","LU0082616367.USD","LU2028103732.USD","LU2491049909.HKD","SG9999004220.SGD","LU0310799852.SGD","LU1093756325.SGD","LU1791710582.SGD","AVEM","MEMX","BK4548","LU1623119135.USD","LU0114720955.EUR","LU0965508806.USD","OZEM","LU2506951958.HKD","LU2357305700.SGD","LU2458330243.SGD","LU2860962120.EUR","LU0323591593.USD","KNOW","LU2237443978.SGD","FENI","BK4599","TSMY","STSM","LU0070302665.USD","LU0345770993.USD","LU2491050071.SGD","LU1989772840.SGD","LU0889565833.HKD","IE0009355771.USD","BK4564","LU1366192091.USD","LU2506951875.HKD","FDTX","LU0882574055.USD","MISL","BK4503","LU1508157978.USD","LU0072462343.USD","LU0823434740.USD","BAI","NVOX","WDGF","LU2471134879.HKD","LU0011850046.USD","LU0359201885.HKD","IDEF","BK4516","LU0823416689.USD","BK4007","CGDG","LU2023250504.SGD","LU0084288322.USD","LU1791710400.SGD","BK4187","LU1023057109.AUD","LU1868838027.USD","LU1291159041.SGD","LU0488056044.USD","LU0882747503.HKD","LU1989764664.SGD","SHLD","LMT","LU2491050154.USD","LU1282649067.USD","LU2362541513.USD","LU1023059063.AUD","LU2271345857.HKD","LU0384037296.USD","LU2506952170.USD","LU1162221912.USD","BK4578","UMMA","EMM","HBMX","LU0432979614.USD","LU0528227936.USD","LU0861579265.USD","LU0345770308.USD","IE00BZ1G4Q59.USD","LU1316542783.SGD","FOWF","NVO","CGIC","LU1934455194.USD","BK4550","BK4512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373511","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373511?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:51","pubTimestamp":1788871865,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Guardant Health (GH) and Neurocrine (N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","NBIX","BK4139","LABU","PJP","LU0029874061.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU0154245673.USD","LU0289739699.SGD","TBXU","BK4535","GNOM","GDOC","IBBQ","LU0889565916.HKD","LU1057294990.SGD","BK4599","IBB","IE0002141913.USD","IE0009355771.USD","LU1061106388.HKD","BK4588","PBE","BK4534","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","BIB","EKG","PTH","LU2468319806.SGD","GNMX","LFSC","LU0109394709.USD","LU2065170008.USD","BK4137","IE00B2B36J28.USD","AMGN","LU0154245756.USD","LU0823416689.USD","HELX","BBH","GH","XLV","FFOX","LU2242646821.SGD","XBI","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","SBIO","GSKH","FHLC","IBBQ","BME","MDTX","RSPH","LLYX","CNCR","CURE","PBE","PJP","JDOC","IBBJ","BIB","CANC","LFSC","SYNB","FTXH","JHMH","PTH","IBRN","BBH","GPCR","TBXU","WDNA","PBPH","NVIB","HYLG","PSCH","SURI","PSIL","IBB","MEDI","BBP","FBT","PINK","FXH","MEDX","MNTL","HRTS","XPH","AZNH","GNMX","APXH","LENZ","GDOC","GNOM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378332","title":"Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378332","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378332?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:26","pubTimestamp":1788870360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GNMX","LU0889565916.HKD","LU0320765992.SGD","GNOM","BK4585","EKG","FFOX","BK4551","GDOC","BK4588","GH","HELX","BK4196","PTH","BK4535","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322709","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322709","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322709?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:15","pubTimestamp":1788866115,"startTime":"0","endTime":"0","summary":"CEA Industries  shares were up over 63% in Tuesday's premarket activity following a 6.1% rise in the prior trading session on Thursday.GMEX Robotics  stock was 23% higher, swinging from the 5.5% loss in the earlier sessionRoivant Sciences  shares were up 23% after the company said its Pulmovant unit's phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD, met its primary and secondary endpoints.Upstream Bio  stock was 11% higher after the company said it presented phase 2 clinical trial results for its lead severe asthma treatment candidate, verekitug, at the European Respiratory Society Congress in Barcelona.Eightco  shares were up 8% following a 6.8% fall in the prior session.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UPB","GMEX","BK4086","BK4200","BK4139","BK4136","ORBS","ROIV","BK4220","PTH","BNC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324029","title":"Roivant Sciences Shares Rise on Positive Mid-Stage Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324029","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324029?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:51","pubTimestamp":1788864660,"startTime":"0","endTime":"0","summary":"Shares of Roivant Sciences climbed after the company disclosed what it called positive results from a mid-stage trial evaluating its treatment for some instances of pulmonary hypertension, or high blo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665248463","title":"Roivant Sciences Jumps After Lung Disease Drug Meets Main Goal in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665248463","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665248463?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:25","pubTimestamp":1788863137,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant Sciences jumps after lung disease drug meets main goal in mid-stage study** Shares of Roivant SciencesROIV.Orise 21.7% to $42.50 premarket** The drug developer's Pulmovant unit says its experimental inhaled therapy, mosliciguat, met the primary goal in a mid-stage study in patients with pulmonary hypertension associated with interstitial lung disease** It is a condition where high blood pressure develops in the lung arteries due to scarring or inflammation in the lungs** The study showed a 56.3% placebo-adjusted reduction in resistance in the lungs' blood vessels at 16 weeks** The drug also met secondary goals: improving six-minute walk distance by 35.2 meters vs placebo; reducing levels of NT-proBNP, a biomarker of cardiac strain, by 53.2% at week 16** Cough, a common side effect associated with inhaled prostacyclin therapies, was reported in 12.1% of patients receiving mosliciguat vs 18.2% on placebo** ROIV says it has already initiated the late-stage study of moslicigua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4139","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321166","title":"Shares of Roivant Sciences up 21.1% Premarket After Experimental Lung Disease Drug Meets Main Goal in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321166?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862233,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}